라벨이 Pharma Bio인 게시물 표시

Even If New Drugs Are a Gamble, Raw Materials, CDMOs, and CROs Win First as the Market Scales Up

Korea’s Pharma-Bio Industry Makes Money from Biosimilars and Manufacturing, Not New Drugs